You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
26 November 2025 - Healthcare solutions provider GE HealthCare (Nasdaq: GEHC) announced on Wednesday that it has received U.S. FDA Premarket Authorization for Pristina Recon DL, a 3D mammography reconstruction technology powered by deep learning. The...
26 November 2025 - Oncology company BeOne Medicines Ltd (Nasdaq: ONC) (HKEX: 06160) (SSE: 688235) announced on Wednesday that the U.S. Food and Drug Administration has granted Priority Review to the company's New Drug Application for sonrotoclax...
26 November 2025 - Remington Medical has confirmed that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its updated VascuChek® Doppler, marking the official commercial launch of the second-generation device. Designed ...
26 November 2025 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) on Wednesday reported positive final Phase 2 immunogenicity and safety results for its Lyme disease vaccine candidate, VLA15.The study showed strong anamnestic immune re...
26 November 2025 - Biopharmaceutical company AstraZeneca PLC (LSE: AZN) (STO: AZN) (Nasdaq: AZN) announced on Wednesday that it has secured US approval for Imfinzi as the first perioperative immunotherapy for adults with resectable early-stage and lo...
26 November 2025 - Danish clinical-stage radiopharmaceuticals company Curasight A/S (Spotlight Stock Market: CURAS) said on Wednesday that it has opened patient enrolment in its phase 1 trial of uTREAT, a targeted radioligand therapy for aggressive b...
26 November 2025 - Prestige Biopharma, a Singapore-based biopharmaceutical company specialising in antibody therapeutics, announced on Tuesday that it has signed an exclusive licence and supply agreement with Biosidus, a biotechnology company headqua...